Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Sawai

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Sawai's Japan sales performance.

Sanofi and Regeneron’s Dupixent receives second positive phase 3 trial results

Sanofi and Regeneron’s Dupixent receives second positive phase 3 trial results Presently, Dupixent is approved in Europe, the US, Japan and other countries worldwide for use in specific patients with moderate-to-severe atopic dermatitis, as well as certain patients with asthma

FDA rejects Takeda’s Eohilia after delays

FDA rejects Takeda’s Eohilia after delays Dupixent is already approved in the US, Europe, Japan and other countries for specific patient populations with atopic dermatitis and asthma.

Novartis strengthens links with BeiGene in a deal that could be worth up to $1bn

Novartis strengthens links with BeiGene in a deal that could be worth up to $1bn Under the new deal, Novartis will make an upfront payment of $300m to obtain the development and commercialisation rights to ociperlimab in the US, EU, Japan, Canada, Mexico and several European

Roche’s Actemra approved for severe COVID-19 in Europe

Roche’s Actemra approved for severe COVID-19 in Europe Actemra/RoActemra is a co-development between Roche and Chugai. It was first approved in Japan in April 2005 and is currently available in more than 110 countries worldwide.

Omicron prompts global action

Omicron prompts global action In fact, Japan has taken even stronger action, banning all foreigners from entering the country from 30 November.

[ Previous 5 results ] 3 4 5 6 7 8 9 10 11 12 [ Next 5 results ]

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Apex.co.uk Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...

Latest intelligence

Report: Reinventing product and portfolio value for the biopharmaceutical industry
Gain practical advice on determining and communicating product and portfolio value, including why, in fast-paced and evolving markets, you need to consider the evidence requirements of a growing network of...
Neil Thompson
How AI is finally helping rare diseases gain more than just attention
By Neil Thompson...
Is communication failing us?
Compelling people to care in a world oversaturated with news and information...